BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakanishi Y, Okamura K, Tsuchikawa T, Nakamura T, Noji T, Asano T, Matsui A, Tanaka K, Murakami S, Ebihara Y, Kurashima Y, Narasaki H, Amano T, Shichinohe T, Hirano S. Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas. Ann Surg Oncol 2020;27:4171-80. [PMID: 32363510 DOI: 10.1245/s10434-020-08534-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li D, Wang L, Cai W, Liang M, Ma X, Zhao X. Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperative pancreatic contrast-enhanced CT findings. European Journal of Radiology 2022. [DOI: 10.1016/j.ejrad.2022.110313] [Reference Citation Analysis]
2 Xu S, Zhang XP, Zhao GD, Zhao ZM, Gao YX, Hu MG, Tan XL, Liu R. Development and validation of an online calculator to predict early recurrence and long-term survival in patients with distal cholangiocarcinoma after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 2021. [PMID: 34676993 DOI: 10.1002/jhbp.1058] [Reference Citation Analysis]
3 Xu S, Zhang XP, Zhao GD, Zou WB, Zhao ZM, Hu MG, Gao YX, Tan XL, Liu Q, Liu R. A novel online calculator to predict recurrence risk in patients with distal cholangiocarcinoma after radical pancreaticoduodenectomy. J Surg Oncol 2021. [PMID: 34617593 DOI: 10.1002/jso.26709] [Reference Citation Analysis]
4 Nooijen LE, Banales JM, de Boer MT, Braconi C, Folseraas T, Forner A, Holowko W, Hoogwater FJH, Klümpen H, Groot Koerkamp B, Lamarca A, La Casta A, López-lópez F, Izquierdo-sánchez L, Scheiter A, Utpatel K, Swijnenburg R, Kazemier G, Erdmann JI. Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry. Cancers 2022;14:2389. [DOI: 10.3390/cancers14102389] [Reference Citation Analysis]
5 Sakata J, Nomura T, Aono T, Kitami C, Yokoyama N, Minagawa M, Takizawa K, Miura K, Hirose Y, Ichikawa H, Nagahashi M, Shimada Y, Kobayashi T, Wakai T. Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates? HPB (Oxford) 2021:S1365-182X(21)00016-2. [PMID: 33558069 DOI: 10.1016/j.hpb.2021.01.007] [Reference Citation Analysis]
6 Li R, Lu Z, Sun Z, Shi X, Li Z, Shao W, Zheng Y, Song J. A Nomogram Based on the Log Odds of Positive Lymph Nodes Predicts the Prognosis of Patients With Distal Cholangiocarcinoma After Surgery. Front Surg 2021;8:757552. [PMID: 34765638 DOI: 10.3389/fsurg.2021.757552] [Reference Citation Analysis]
7 Shimizu A, Motoyama H, Kubota K, Notake T, Fukushima K, Ikehara T, Hayashi H, Yasukawa K, Kobayashi A, Soejima Y. Safety and Oncological Benefit of Hepatopancreatoduodenectomy for Advanced Extrahepatic Cholangiocarcinoma with Horizontal Tumor Spread: Shinshu University Experience. Ann Surg Oncol. 2021;28:2012-2025. [PMID: 33044629 DOI: 10.1245/s10434-020-09209-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Yamada T, Nakanishi Y, Hayashi H, Tanishima S, Mori R, Fujii K, Okamura K, Tsuchikawa T, Nakamura T, Noji T, Asano T, Matsui A, Tanaka K, Watanabe Y, Kurashima Y, Ebihara Y, Murakami S, Shichinohe T, Mitsuhashi T, Hirano S. Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma. HPB (Oxford) 2021:S1365-182X(21)01703-2. [PMID: 34903468 DOI: 10.1016/j.hpb.2021.11.008] [Reference Citation Analysis]
9 Chin KM, Di Martino M, Syn N, Ielpo B, Hilal MA, Goh BKP, Koh YX, Prieto M. Re-appraising the role of lymph node status in predicting survival in resected distal cholangiocarcinoma - A meta-analysis and systematic review. Eur J Surg Oncol 2021;47:1267-77. [PMID: 33549378 DOI: 10.1016/j.ejso.2021.01.004] [Reference Citation Analysis]